Pharmacological treatment in major depressive disorder and treatment-resistant depression in clinical practice: A retrospective cohort study
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: A substantial proportion of patients treated for major depressive disorder (MDD) do not respond to two or more pharmacological antidepressant treatments, classified as treatment-resistant depression (TRD). Clinical guidelines provide recommendations for subsequent steps in pharmacological management of MDD and TRD, yet little is known about real-world effectuation of guidelines in clinical practice. This study investigated MDD pharmacological treatment patterns in the Netherlands, specifically focusing on pharmacy-defined TRD. METHODS: Psychiatric diagnoses in secondary mental healthcare registrations were combined with pharmacy data to retrieve prescriptions of psychotropic medication in adults with a primary MDD diagnosis (N = 6832). Pharmacological treatment prescribed in primary or secondary care was evaluated 12 months before and 12 months after the first registered MDD diagnosis. RESULTS: Selective serotonin reuptake inhibitors (SSRIs) comprised the first-line treatment in most (50.4%) MDD patients. Overall, 43.3% of patients changed antidepressant treatment, with augmentation with an atypical antipsychotic or a switch to another SSRI or tetracyclic antidepressants being frequently observed. Notably, 20.7% of patients received three or more steps of antidepressant treatment, meeting the study's pharmacy-based definition of TRD. While 65.3% of treatment patterns in MDD aligned with clinical guidelines, only 13.8% of pharmacy-defined TRD treatment patterns were guideline-adherent across steps one to three and 11.0% in steps three to five. CONCLUSIONS: Initial treatment was often in accordance with clinical guidelines for MDD, yet treatment patterns in pharmacy-defined TRD were heterogeneous and mostly not guideline-adherent. Findings suggest that the implementation of professional recommendations in clinical practice remains challenging, especially for TRD.
Source: Journal of Psychiatric Research
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,320
Funder: Cilag
OpenAlex ID: W7236592669
